Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-06-27 02:10 CEST (UTC+2h)
 

Calculation of Group effect for FDA studies [RSABE / ABEL]

posted by GM - India, 2017-06-09 08:10  - Posting: # 17473
Views: 426

Dear All,

What are necessary terms need to be used in ANOVA model, when the study conducted in cohorts (more than one group)...?

Every time I got confused with this.

Kindly suggest, any guidance is available.

Thanks in advance,
GM

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,007 Posts in 3,644 Threads, 1,043 registered users;
16 users online (0 registered, 16 guests).

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed